ANNEX III, Regulation (EU) 2020/686

In forcesince 10 Apr 2023cited 2×
1.

All instruments used for the collection, processing, preservation or freezing of semen shall be cleansed and either disinfected or sterilised before use, except for new single-use instruments.

2.

Frozen semen shall:

(a)

be placed and stored in storage containers:

(i)

which have been cleansed and either disinfected or sterilised before use, or which are new single-use containers;

(ii)

with a cryogenic agent, which must not have previously been used for other biological products originating from animals;

(b)

prior to dispatch or use, be stored in approved conditions for a minimum period of 30 days from the date of collection.

3.

Where necessary, antibiotics or mixtures of antibiotics may be added to semen or contained in semen diluents.

4.

In respect of semen of bovine animals, antibiotics or mixtures of antibiotics referred to in point 3(a), (b) and (c) or antibiotics or mixtures of antibiotics with a bactericidal activity at least equivalent to that of the antibiotics or their mixtures referred to in point 3(a), (b) and (c), or semen diluents containing such antibiotics or mixtures of antibiotics, shall be added and be effective in particular against campylobacters, leptospires and mycoplasmas.

5.

In respect of semen of porcine animals, antibiotics or mixtures of antibiotics referred to in point 3(a), (b) and (c) or antibiotics or mixtures of antibiotics with a bactericidal activity at least equivalent to that of the antibiotics or their mixtures referred to in point 3(a), (b) and (c), or semen diluents containing such antibiotics or mixtures of antibiotics, shall be added and be effective in particular against leptospires.

6.

Where an antibiotic or a mixture of antibiotics is(are) added to semen:

(a)

the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the semen diluent containing antibiotics shall be stated in the animal health certificate accompanying the consignment;

(b)

it(they) shall be added to the semen after final dilution or to the diluent;

(c)

in the case of frozen semen, it(they) shall be added before the semen is frozen.

7.

For frozen or chilled semen, immediately after the addition of the antibiotics, the diluted semen shall be kept at:

(a)

a temperature of at least 5 °C, except in the case of semen of porcine animals, which may be kept at a temperature of at least 15 °C for a period of not less than 45 minutes; or

(b)

a time-temperature regime with a documented equivalent bactericidal activity.

In vivo derived embryos shall be collected, processed and preserved in accordance with the following requirements:

1.

Embryos shall be collected and processed by an embryo collection team, without coming into contact with any other consignment of embryos not complying with the requirements of this Regulation.

2.

Embryos shall be collected in a place which is separated from other parts of the premises or establishment and which shall be kept in good repair and constructed with materials which permit its effective and easy cleansing and disinfection.

3.

Embryos shall be processed (examined, washed, treated and placed in straws or other packages) in either a permanently located laboratory or a mobile laboratory.

4.

All equipment used to collect, handle, wash, freeze and store embryos shall be cleansed and either disinfected or sterilised before use, according to the IETS Manual, or be a new single-use equipment.

5.

Any biological product originating from animals used in the media and solutions for the collection, processing, washing or storage of embryos shall be free from pathogenic microorganisms. Media and solutions used in the collection, freezing and storage of embryos shall be sterilised by methods approved in accordance with the IETS Manual and handled in such a manner as to ensure sterility.

6.

Where, according to the IETS Manual, antibiotics or a mixture of antibiotics are added to the collection, processing, washing and storage media, the names of the antibiotics added and their concentration shall be stated in the animal health certificate accompanying the consignment.

7.

The cryogenic agents used for the preservation or storage of embryos shall not have previously been used for other biological products originating from animals.

8.

The embryos shall be washed according to the IETS Manual and have an intact zona pellucida or, in the case of equine embryos, the embryonic capsule, before and immediately after washing. Each embryo shall be washed at least 10 times in a special fluid for embryos, which shall be changed each time. Each wash shall be a 100-fold dilution of the previous wash and a sterile micropipette shall be used to transfer the embryo on each occasion.

The standard washing procedure shall be modified to include additional washes with the enzyme trypsin, according to the IETS Manual, when inactivation or removal of certain pathogens is required.

9.

Embryos from different donor animals shall not be washed together.

10.

The zona pellucida or, in the case of equine embryos, the embryonic capsule of each embryo shall be examined over its entire surface area at not less than 50× magnification and certified to be intact and free of adherent material.

11.

Embryos that have successfully undergone the examination set out in point 10 shall be placed in a cleansed and either disinfected or sterile, except for a new single-use, straw or another package which is marked in accordance with Article 10(1) and (5) and which shall be sealed immediately.

12.

Each embryo shall, where appropriate, be frozen as soon as possible and stored in a storage premises, referred to in point 2(b) of Part 2 of Annex I, which is under the responsibility of the team veterinarian.

13.

Where there is no other procedure to verify the health status of the donor animals, or in order to verify compliance with the animal health and biosecurity requirements laid down by the team veterinarian, including in the framework of the quality control scheme referred to in point 1(b) of Part 2 of Annex I, the embryo collection team shall, in accordance with the IETS Manual, submit to an official or authorised by the competent authority laboratory routine samples of non-viable embryos or oocytes, flushing fluids or washing fluids resulting from its activities for the detection of bacterial and viral contamination at a frequency to be established by the team veterinarian.

In addition to the requirements set out in Part 2, the following additional requirements shall apply to the collection, processing and transport of oocytes, ovaries and other tissues for use in in vitro fertilisation and in vitro culture:

1.

The ovaries and other tissues collected at a slaughterhouse, either from an individual donor animal or from a batch of donor animals, shall be collected in a slaughterhouse approved in accordance with Article 148 of Regulation (EU) 2017/625.

Those potential donor animals must have undergone ante-mortem and post-mortem inspections carried out by a veterinarian at the slaughterhouse who must have certified them to be free of symptoms and signs of any of the category A, B, C and D diseases relevant for the bovine, porcine, ovine, caprine or equine animals.

The slaughterhouse must be situated in an area where foot-and-mouth disease has not been reported within a 10-km radius for a period of at least the preceding 30 days before the date of collection of the ovaries and other tissues.

2.

Ovaries shall not be brought into the laboratory of an embryo production team for processing until a post-mortem inspection of donor animals is completed with satisfactory results.

If a disease referred to in point 1 is found in the individual donor animal, the batch of donor animals or in any animals slaughtered in that slaughterhouse on that day, all ovaries and other tissues from those donor animals shall be traced and discarded.

3.

Equipment for the removal and transport of ovaries and other tissues shall be cleansed and either disinfected or sterilised before use, except for new single-use equipment, and exclusively used for those purposes.

Separate equipment shall be used to handle oocytes and embryos from different individual donor animals and from different batches of donor animals.

In addition to the requirements set out in Part 2, the following additional requirements shall apply to the processing of in vitro produced embryos:

1.

After the in vitro culture period is completed, but prior to the freezing, storage and transport of the embryos, they shall be washed and undergo the treatments referred to in points 7, 10 and 11 of Part 2.

2.

Embryos from different individual donor animals or from different batches of donor animals, referred to in point 1 of Part 3, shall not be washed together.

3.

Embryos from different individual donor animals or from different batches of donor animals shall not be placed in the same straw or other package.

Prior to any micromanipulation which compromises the integrity of the zona pellucida or, in the case of equine embryos, the embryonic capsule, all embryos or oocytes shall be collected and processed in accordance with the animal health requirements set out in Parts 2, 3 and 4.

In addition, the following requirements shall apply:

1.

Where micromanipulation of the embryo which involves penetration of the zona pellucida or, in the case of equine embryos, the embryonic capsule, this shall be carried out in a laboratory referred to in point 2(a) of Part 3 of Annex I, which is under the responsibility of the team veterinarian.

2.

Each embryo production team shall keep records of its activities in accordance with Article 8(1)(b).

In the case of embryos produced by in vitro fertilisation, the identification of the embryos may be done on the basis of a batch of donor animals, but shall contain details of the date and place of collection of ovaries and oocytes. It shall also allow the establishment of origin of the donor animals to be traced.

3.

Any micromanipulation which involves penetration of the zona pellucida or, in the case of equine embryos, the embryonic capsule, shall be carried out in the facilities approved for that purpose, and after the last wash and examination.

Such micromanipulation may only be carried out on an embryo with an intact zona pellucida or, in the case of equine embryos, an intact embryonic capsule.

1.

Each embryo collection team and embryo production team shall ensure that the embryos and oocytes are stored at suitable temperatures in storage premises referred to in point 2(b) of Part 2 of Annex I.

2.

Only embryos collected by an embryo collection team, or oocytes collected by and embryos produced by an embryo production team, and transported in conditions ensuring that cross-contamination of embryos and oocytes is prevented, as they have had no contact with embryos and oocytes which do not comply with the requirements laid down in this Regulation, may be brought into the storage premises referred to in point 2(b) of Part 2 of Annex I.

In vivo derived embryos, in vitro produced embryos and oocytes shall be stored in distinct storage containers assigned for each type of germinal product and the handling of stored germinal products of different types and species must be carried out by separate staff or at a different time.

3.

The team veterinarian may decide that embryos not collected by an embryo collection team, or oocytes not collected and embryos not produced by an embryo production team, may be processed by the embryo collection team or the embryo production team provided that:

(a)

such oocytes and embryos are collected from animals which fulfil the conditions laid down:

(i)

in respect of bovine animals, in point 1 of Chapter II of Part 1 of Annex II and as applicable in Chapters I, II and III of Part 5 of Annex II;

(ii)

in respect of porcine animals, in points 1, 2 and 3 of Chapter II of Part 2 of Annex II and as applicable in Chapters I and IV of Part 5 of Annex II;

(iii)

in respect of ovine and caprine animals, in point 1 of Chapter II of Part 3 of Annex II and as applicable in Chapters I to III of Part 5 of Annex II;

(iv)

in respect of equine animals, in points 1 and 2 of Chapter II of Part 4 of Annex II;

(b)

processing is carried out with separate equipment or at a different time from oocytes and embryos intended to be moved to another Member State, the equipment in the latter case being cleaned and sterilised after use;

(c)

such oocytes and embryos shall not be moved to another Member State and shall not at any time come into contact with, or be stored with, oocytes and embryos intended to be moved to another Member State;

(d)

such oocytes and embryos must be identifiable by a marking which is different from that referred to in point 1(a)(v) of Part 1 of Annex I.

4.

Frozen embryos or oocytes shall, prior to dispatch to another Member State, be stored in storage premises referred to in point 2(b) of Part 2 of Annex I for a period of at least 30 days from the date of their collection or production.

5.

Only embryos or oocytes from an individual donor animal or from one batch of donor animals, referred to in point 1 of Part 3, shall be placed in the same straw or another package.